NO20063576L - 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes - Google Patents

1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes

Info

Publication number
NO20063576L
NO20063576L NO20063576A NO20063576A NO20063576L NO 20063576 L NO20063576 L NO 20063576L NO 20063576 A NO20063576 A NO 20063576A NO 20063576 A NO20063576 A NO 20063576A NO 20063576 L NO20063576 L NO 20063576L
Authority
NO
Norway
Prior art keywords
obesity
diabetes
treatment
analogous compounds
dioxane derivatives
Prior art date
Application number
NO20063576A
Other languages
English (en)
Inventor
Braj Bhushan Lohray
Vidya Bhushan Lohray
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of NO20063576L publication Critical patent/NO20063576L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives nye forbindelser med formel (I) og deres farmasøytisk brukbare preparater som modulatorer av PPAR-ligander.
NO20063576A 2004-01-09 2006-08-07 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes NO20063576L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN23MU2004 2004-01-09
PCT/IN2005/000011 WO2005077943A1 (en) 2004-01-09 2005-01-07 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes

Publications (1)

Publication Number Publication Date
NO20063576L true NO20063576L (no) 2006-10-06

Family

ID=34856875

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063576A NO20063576L (no) 2004-01-09 2006-08-07 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes

Country Status (14)

Country Link
US (1) US20070105847A1 (no)
EP (1) EP1709035A1 (no)
JP (1) JP2007517862A (no)
CN (1) CN1930152A (no)
AP (1) AP2006003688A0 (no)
AU (1) AU2005213545B2 (no)
BR (1) BRPI0506477A (no)
CA (1) CA2555817A1 (no)
EA (1) EA200601295A1 (no)
IL (1) IL176758A0 (no)
NO (1) NO20063576L (no)
OA (1) OA13359A (no)
WO (1) WO2005077943A1 (no)
ZA (1) ZA200605731B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007096261A2 (en) * 2006-02-21 2007-08-30 F. Hoffmann-La Roche Ag Process for the preparation of dioxane derivatives
WO2007099553A2 (en) 2006-02-27 2007-09-07 Cadila Healthcare Limited 1,3-dioxane carboxylic acids
CA2676444C (en) * 2007-01-18 2013-07-30 Evolva Sa Prodrugs of substituted 1,3-dioxanes and their uses
WO2008089462A2 (en) 2007-01-18 2008-07-24 Evolva Sa Substituted 1,3-dioxanes and their uses
AR085872A1 (es) 2011-04-08 2013-10-30 Basf Se Derivados heterobiciclicos n-sustituidos utiles para combatir parasitos en plantas y/o animales, composiciones que los contienen y metodos para combatir dichas plagas
KR20140048257A (ko) 2011-07-15 2014-04-23 바스프 에스이 동물 해충을 퇴치하기 위해 치환된 3-피리딜 티아졸 화합물 및 유도체 i을 사용하는 살충 방법
IN2014CN01136A (no) 2011-08-12 2015-04-10 Basf Se
WO2013079600A1 (en) 2011-12-02 2013-06-06 Basf Se Method and system for monitoring crops during storage
WO2013079601A1 (en) 2011-12-02 2013-06-06 Basf Se Method and system for monitoring crops and/or infestation of crops with harmful organismus during storage
US20140309109A1 (en) 2011-12-21 2014-10-16 Basf Se N-Thio-anthranilamide compounds and their use as pesticides
BR112014015553B1 (pt) 2011-12-23 2020-02-27 Basf Se Compostos de isotiazolina, método de preparação de compostos, composição agrícola ou veterinária, usos de um composto e método para proteger plantas
WO2013113789A1 (en) 2012-02-02 2013-08-08 Basf Se N-thio-anthranilamide compounds and their use as pesticides
WO2013144228A1 (en) 2012-03-29 2013-10-03 Basf Se Pesticidal methods using heterocyclic compounds and derivatives for combating animal pests
BR112014027133A2 (pt) 2012-05-09 2017-06-27 Basf Se compostos, composição agrícola ou veterinária, método para o controle das pragas de invertebrados, material de propagação dos vegetais e método para o tratamento ou proteção de um animal.
MX2015008110A (es) 2012-12-21 2015-11-06 Basf Se Cicloclavina y derivados de esta para controlar plagas de invertebrados.
WO2014128136A1 (en) 2013-02-20 2014-08-28 Basf Se Anthranilamide compounds and their use as pesticides
CN112370455A (zh) * 2020-10-19 2021-02-19 济南大学 一种磺酰胺衍生物作为α-葡萄糖苷酶抑制剂及其应用
CN114315802B (zh) * 2021-12-14 2023-06-16 西安医学院 一种喹唑啉含氮杂环衍生物及制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781222A1 (fr) * 1998-07-17 2000-01-21 Lipha Composes cycliques utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procede de preparation
AU2001258841B2 (en) * 2000-05-26 2005-06-23 Nippon Shinyaku Co., Ltd. Heterocyclic compounds

Also Published As

Publication number Publication date
AP2006003688A0 (en) 2006-08-31
IL176758A0 (en) 2006-10-31
AU2005213545A1 (en) 2005-08-25
JP2007517862A (ja) 2007-07-05
OA13359A (en) 2007-04-13
CA2555817A1 (en) 2005-08-25
CN1930152A (zh) 2007-03-14
EA200601295A1 (ru) 2006-12-29
US20070105847A1 (en) 2007-05-10
ZA200605731B (en) 2007-11-28
AU2005213545B2 (en) 2008-06-26
WO2005077943A1 (en) 2005-08-25
EP1709035A1 (en) 2006-10-11
BRPI0506477A (pt) 2007-02-06

Similar Documents

Publication Publication Date Title
NO20066055L (no) Pyridinderivater
NO20082445L (no) Neuropeptid-2 reseptor-agonister
NO20070855L (no) Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer.
NO20055516L (no) Kannabinoidreceptorligander og anvendelser derav
NO20064288L (no) Tetraazabenzo(E)azulen-derivater og angaloger derav
EA200600203A1 (ru) Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2
NO20044534L (no) Substituerte fenylacetamider og deres anvendelse som glukokinaseaktivatorer
NO20054852L (no) GFAT inhibitorer
NO20050828L (no) lndol-3-svovelderivater
NO20092033L (no) Nye forbindelser
ATE407938T1 (de) Glucopyranosyl-substituierte benzen-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
NO20084912L (no) Bisykliske derivater som CETP-inhibitorer
DE602005017895D1 (de) Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
NO20081217L (no) Nye benzotiazolonderivater
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
NO20044763L (no) 1-(aminoalkyl)-3-sulfonylazaindoler som 5-hydroksytryptamin-6 ligander
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
NO20062357L (no) Indolinderivater og anvendelse av dem ved behandling av sykdomstilstander som cancer
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
NO20070570L (no) Forbindelser.
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20090282L (no) Syklopropylaminderivater som histamin H3 reseptormodulatorer
NO20082214L (no) 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer
NO20065733L (no) Naftalinderivater nyttige som histamin-3-reseptor ligander
NO20054787D0 (no) Indenderivater som farmasotiske midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application